Global burden of polycystic ovary syndrome in women of reproductive age, 1990–2021: Analysis of the global burden of disease study 2021 with projections to 2050
PLOS One · 2025
DOI: 10.1371/journal.pone.0333000 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Xinkuo Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Central Hospital of Dalian University of Technology, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Global Burden of Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the global burden of polycystic ovary syndrome (PCOS) among women of reproductive age from 1990 to 2021.
Methods
This study analyzed population-based data from the Global Burden of Disease (GBD) database on the incidence, prevalence, and disability-adjusted life years (DALYs) of PCOS in reproductive-aged women. Age-standardized rates for incidence (ASIR), prevalence (ASPR), and DALYs (ASDR) were calculated per 100,000 population, with 95% uncertainty intervals (UIs). Data from 204 countries and territories were stratified by age, location, and socio-demographic index (SDI).
Results
Globally, the burden of PCOS among reproductive-aged women in 2021 was characterized by ASIR of 64.44 (95% UI: 39.07, 103.40) per 100,000 population, ASPR of 3364.53 (95% UI: 2395.08, 4681.81) per 100,000 population, and ASDR of 29.51 (95% UI: 13.09, 61.49) per 100,000 population. Moreover, the pace of increase in ASIR, ASPR, and ASDR accelerated during 1990–2021, with estimated annual percentage change (EAPC) of 0.65 (95% CI: 0.62, 0.69), 0.74 (95% CI: 0.70, 0.77), and 0.72 (95% CI: 0.68, 0.76), respectively. Among the five SDI regions, the middle SDI region exhibited the highest EAPCs for incidence (1.39; 95% CI: 1.34, 1.43), prevalence (1.39; 95% CI: 1.34, 1.43), and DALYs (1.73; 95% CI: 1.69, 1.78). Regionally, the High-income Asia Pacific region demonstrated the highest ASIR of 308.16 (95% UI: 485.83, 171.53) per 100,000 population. At the national level, Japan exhibited the highest ASIR of 360.92 (95% UI: 199.08, 573.59) per 100,000 population.
Conclusion
The global burden of PCOS among women of reproductive age has shown a consistent upward trend in incidence, prevalence, and DALYs. A comprehensive understanding of the epidemiology of PCOS among women of reproductive age is essential for informing targeted prevention strategies and optimizing disease control measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmacy, Central Hospital of Dalian University of Technology, Dalian, Liaoning, China.
- Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
- Department of Infectious Diseases, Central Hospital of Dalian University of Technology, Dalian, Liaoning, China.
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
- Department of Colorectal Surgery, Liaoning Cancer Institute and Hospital, Shenyang, Liaoning, China.
ORCID-Profile: Xinkuo Zheng
Zitieren
APA
Zheng, X., Liu, M., Bai, Z., Wu, L., Geng, L., Shen, Y., Na, J., Qiu, H., & Xi, Y. (2025). Global burden of polycystic ovary syndrome in women of reproductive age, 1990–2021: Analysis of the global burden of disease study 2021 with projections to 2050. PLOS One. https://doi.org/10.1371/journal.pone.0333000
Vancouver
Zheng X, Liu M, Bai Z, Wu L, Geng L, Shen Y, et al. Global burden of polycystic ovary syndrome in women of reproductive age, 1990–2021: Analysis of the global burden of disease study 2021 with projections to 2050. PLOS One. 2025. doi:10.1371/journal.pone.0333000
BibTeX
@article{Zheng2025,
author = {Zheng, Xinkuo and Liu, Meishen and Bai, Zhaohui and Wu, Ling and Geng, Lili and Shen, Yun and Na, Jing and Qiu, Haonan and Xi, Yalin},
title = {Global burden of polycystic ovary syndrome in women of reproductive age, 1990–2021: Analysis of the global burden of disease study 2021 with projections to 2050},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0333000}
}
EUVIMED